A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy

NCT05937152 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no participants enrolled

Conditions

Diabetic Polyneuropathy

Interventions

DRUG: Eptinezumab
DRUG: Placebo

Sponsor

Mayo Clinic